Ascending cholangitis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 34: Line 34:


* [[Prognosis]] is good in patients who have quick and adequate drainage where there is improvement in [[Hemodynamics|hemodynamic]] and [[inflammatory]] parameters.
* [[Prognosis]] is good in patients who have quick and adequate drainage where there is improvement in [[Hemodynamics|hemodynamic]] and [[inflammatory]] parameters.
* Poor outcomes are seen if urgent surgery is required for drainage.


OR
Prognosis of disease depends on the severity of the illness. Poor outcomes are seen if urgent surgery is required for drainage. Severe ascending cholangitis is associated with organ dysfunction in one or more organ as described below<ref name="KiriyamaTakada2013">{{cite journal|last1=Kiriyama|first1=Seiki|last2=Takada|first2=Tadahiro|last3=Strasberg|first3=Steven M.|last4=Solomkin|first4=Joseph S.|last5=Mayumi|first5=Toshihiko|last6=Pitt|first6=Henry A.|last7=Gouma|first7=Dirk J.|last8=Garden|first8=O. James|last9=Büchler|first9=Markus W.|last10=Yokoe|first10=Masamichi|last11=Kimura|first11=Yasutoshi|last12=Tsuyuguchi|first12=Toshio|last13=Itoi|first13=Takao|last14=Yoshida|first14=Masahiro|last15=Miura|first15=Fumihiko|last16=Yamashita|first16=Yuichi|last17=Okamoto|first17=Kohji|last18=Gabata|first18=Toshifumi|last19=Hata|first19=Jiro|last20=Higuchi|first20=Ryota|last21=Windsor|first21=John A.|last22=Bornman|first22=Philippus C.|last23=Fan|first23=Sheung-Tat|last24=Singh|first24=Harijt|last25=de Santibanes|first25=Eduardo|last26=Gomi|first26=Harumi|last27=Kusachi|first27=Shinya|last28=Murata|first28=Atsuhiko|last29=Chen|first29=Xiao-Ping|last30=Jagannath|first30=Palepu|last31=Lee|first31=Sung Gyu|last32=Padbury|first32=Robert|last33=Chen|first33=Miin-Fu|last34=Dervenis|first34=Christos|last35=Chan|first35=Angus C.W.|last36=Supe|first36=Avinash N.|last37=Liau|first37=Kui-Hin|last38=Kim|first38=Myung-Hwan|last39=Kim|first39=Sun-Whe|title=TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)|journal=Journal of Hepato-Biliary-Pancreatic Sciences|volume=20|issue=1|year=2013|pages=24–34|issn=18686974|doi=10.1007/s00534-012-0561-3}}</ref>;
 
* Hypotension requiring dopamine ≥5 μg/kg per min, or any dose of nor-epinephrine
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
* Altered mental status or disturbance of consciousness
 
* Respiratory Compromise - PaO2/FiO2 ratio <300
Natural History, Complications, and Prognosis
* Renal dysfunction - Oliguria and serum creatinine >2.0 mg/dl
Natural History
* Hepatic abnormalities with PT‐INR >1.5
The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
* Hematological dysfuction - Platelet count <100,000/mm3
The symptoms of (disease name) typically develop ___ years after exposure to ___.
Other bad prognostic factor in addition to organ dysfuction include hypoalbuminemia<ref name="TsuyuguchiSugiyama2012">{{cite journal|last1=Tsuyuguchi|first1=Toshio|last2=Sugiyama|first2=Harutoshi|last3=Sakai|first3=Yuji|last4=Nishikawa|first4=Takao|last5=Yokosuka|first5=Osamu|last6=Mayumi|first6=Toshihiko|last7=Kiriyama|first7=Seiki|last8=Yokoe|first8=Masamichi|last9=Takada|first9=Tadahiro|title=Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines|journal=Journal of Hepato-Biliary-Pancreatic Sciences|volume=19|issue=5|year=2012|pages=557–565|issn=18686974|doi=10.1007/s00534-012-0538-2}}</ref>
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
Common complications of [disease name] include:
[Complication 1]
[Complication 2]
[Complication 3]
Prognosis
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
[Subtype of disease/malignancy] is associated with the most favorable prognosis.
The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.


==References==
==References==

Revision as of 15:51, 26 September 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]

Overview

Natural History

Ascending Cholangitis, also known as acute cholangitis is a systemic disease caused by the inflammation and infection of the biliary tree most commonly following an obstruction in the biliary tract. It is characterized by a triad (Charcot's Triad) of fever, jaundice and right upper quadrant pain. A pentad (also known as Reynold's pentad) can also be seen in which altered mental status and sepsis are present in addition to usual findings. The severity of disease range anywhere from mild infection to life-threatening sepsis by the translocation of bacteria into the bloodstream[1]. If left untreated, patients with ascending cholangitis may progress to develop severe sepsis and multiorgan failure leading to death[2]

Complications

Some complications of ascending cholangitis include[3];

  • Sepsis - Gram negative bacteremia
  • Hepatic abcesses
  • Liver failure
  • Renal Failure
  • Pancreatitis

Other complications that are seen in ascending cholangitis patients can occur following the treatment . Post-operative complications may include[4];

  • Pneumonia
  • Respiratory failure
  • Heart failure
  • Cardiac arrythmias
  • Cardiac ischemia
  • Gastrointestinal Bleeding
  • Bile leaking into peritoneum or abdomen
  • Renal abcess
  • Fistulae
  • Wound infection
  • Wound dehiscence
  • Disseminated intravascular coagulation (DIC)

Prognosis

  • Acute cholangitis bears a significant risk of death, with the leading cause being irreversible shock with multiple organ failure (which could have multiple possible complications of severe infections). Modern improvements in diagnosis and treatment have led to a reduction in mortality.
  • Before 1980, the mortality rate was greater than 50%; However, in the past thirty years, it has decreased to 10-30%[5].[6]. Mortality rate after the year 2000 was found to be 2700-10,000 per 100,000[7]. These differences in mortality can likely be attributed to improvements in early diagnosis and supportive treatment.
  • Patients with signs of multiple organ failure have a high mortality risk and need urgent biliary drainage and treatment with systemic antibiotics. Other causes of death following severe cholangitis include heart failure and pneumonia.

Prognosis of disease depends on the severity of the illness. Poor outcomes are seen if urgent surgery is required for drainage. Severe ascending cholangitis is associated with organ dysfunction in one or more organ as described below[8];

  • Hypotension requiring dopamine ≥5 μg/kg per min, or any dose of nor-epinephrine
  • Altered mental status or disturbance of consciousness
  • Respiratory Compromise - PaO2/FiO2 ratio <300
  • Renal dysfunction - Oliguria and serum creatinine >2.0 mg/dl
  • Hepatic abnormalities with PT‐INR >1.5
  • Hematological dysfuction - Platelet count <100,000/mm3

Other bad prognostic factor in addition to organ dysfuction include hypoalbuminemia[9]

References

  1. Boey JH, Way LW (1980). "Acute cholangitis". Ann Surg. 191 (3): 264–70. PMC 1344694. PMID 7362292.
  2. Muir CA (2004). "Acute ascending cholangitis". Clin J Oncol Nurs. 8 (2): 157–60. doi:10.1188/04.CJON.157-160. PMID 15108417.
  3. el Rifaei A, Hassouna M, Fouda A, Latt R, Sawan M, Duval F; et al. (1989). "The effect of early bladder stimulation on spinal shock: a preliminary report". J Urol. 141 (4): 1010–3. PMID 2784509.
  4. Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK; et al. (1990). "Emergency surgery for severe acute cholangitis. The high-risk patients". Ann Surg. 211 (1): 55–9. PMC 1357893. PMID 2294844.
  5. Thompson JE, Pitt HA, Doty JE, Coleman J, Irving C (1990). "Broad spectrum penicillin as an adequate therapy for acute cholangitis". Surg Gynecol Obstet. 171 (4): 275–82. PMID 2218831.
  6. Salek J, Livote E, Sideridis K, Bank S (2009). "Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis". J Clin Gastroenterol. 43 (2): 171–5. doi:10.1097/MCG.0b013e318157c62c. PMID 18769362.
  7. Kimura Y, Takada T, Strasberg SM, Pitt HA, Gouma DJ, Garden OJ; et al. (2013). "TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Sci. 20 (1): 8–23. doi:10.1007/s00534-012-0564-0. PMID 23307004.
  8. Kiriyama, Seiki; Takada, Tadahiro; Strasberg, Steven M.; Solomkin, Joseph S.; Mayumi, Toshihiko; Pitt, Henry A.; Gouma, Dirk J.; Garden, O. James; Büchler, Markus W.; Yokoe, Masamichi; Kimura, Yasutoshi; Tsuyuguchi, Toshio; Itoi, Takao; Yoshida, Masahiro; Miura, Fumihiko; Yamashita, Yuichi; Okamoto, Kohji; Gabata, Toshifumi; Hata, Jiro; Higuchi, Ryota; Windsor, John A.; Bornman, Philippus C.; Fan, Sheung-Tat; Singh, Harijt; de Santibanes, Eduardo; Gomi, Harumi; Kusachi, Shinya; Murata, Atsuhiko; Chen, Xiao-Ping; Jagannath, Palepu; Lee, Sung Gyu; Padbury, Robert; Chen, Miin-Fu; Dervenis, Christos; Chan, Angus C.W.; Supe, Avinash N.; Liau, Kui-Hin; Kim, Myung-Hwan; Kim, Sun-Whe (2013). "TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)". Journal of Hepato-Biliary-Pancreatic Sciences. 20 (1): 24–34. doi:10.1007/s00534-012-0561-3. ISSN 1868-6974.
  9. Tsuyuguchi, Toshio; Sugiyama, Harutoshi; Sakai, Yuji; Nishikawa, Takao; Yokosuka, Osamu; Mayumi, Toshihiko; Kiriyama, Seiki; Yokoe, Masamichi; Takada, Tadahiro (2012). "Prognostic factors of acute cholangitis in cases managed using the Tokyo Guidelines". Journal of Hepato-Biliary-Pancreatic Sciences. 19 (5): 557–565. doi:10.1007/s00534-012-0538-2. ISSN 1868-6974.

Template:WikiDoc Sources